BIOINFORMATICS SHARED RESOURCE The Bioinformatics SR (BIOIN) is a vital component of the Center?s entire research operation. It houses all databases, date storage, and analytic infrastructure central to Lineberger?s research. Two major functions of the SR are 1) the maintenance of all databases, substantial computational and data storage infrastructure in a secure yet utilitarian computing environment and; 2) a full complement of research services to faculty for ?big data? analysis and the development of new analytic techniques. An example of these services includes the management of the Laboratory Information Management System (LIMS) used for tissue tracking which promotes the seamless transfer of samples from group to group. The LIMS integrates with other applications such as the Lineberger Data & Biospecimens Repository and Tableau for report generation. LIMS currently supports 10 SR, encompassing 7,628 active protocols, and 2.5M containers. The SR is central to the handling and analysis of tissue-based clinical genomics studies such as UNCsequel and those 9 institutional trials. The facility is a primary partner for faculty in sequencing processes for DNA and RNA and drive new tools for discovery and results in publications such as Perou & Parker, Bioinformatics 2019,and Kim et al. Nat Methods, 2018) Another example is the involvement of BIOIN in every TCGA paper since 2016 (48 in total). BIOIN request a CCSG budget of $264,702 which represents 8% of its operating costs and is requested to support the salary of key personnel for effort in support of cancer research and bioinformatic analysis. This facility was used by nearly 100 members for bioinformatics analysis in fiscal year 2019. The facility is a Lineberger exclusive resource and as such the users were 100% members in 2019. The import of the core and its scientific infrastructure is illustrated by the ~$3.5M annual LCCC investment in its operation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089831
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Ma, Shaohua; Paiboonrungruan, Chorlada; Yan, Tiansheng et al. (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434:164-172
Aung, Kyaw L; Fischer, Sandra E; Denroche, Robert E et al. (2018) Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res 24:1344-1354
Suh, Junghyun L; Watts, Brian; Stuckey, Jacob I et al. (2018) Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry 57:2140-2149
Brock, William J; Beaudoin, James J; Slizgi, Jason R et al. (2018) Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease. Int J Toxicol 37:144-154
Thomas, Nancy E; Edmiston, Sharon N; Tsai, Yihsuan S et al. (2018) Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. Am J Dermatopathol :
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Hall, Marissa G; Marteau, Theresa M; Sunstein, Cass R et al. (2018) Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med 41:398-405
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Wu, Bing; Zhang, Song; Guo, Zengli et al. (2018) RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs. Immunity 49:886-898.e5
Ding, Li; Bailey, Matthew H; Porta-Pardo, Eduard et al. (2018) Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell 173:305-320.e10

Showing the most recent 10 out of 1525 publications